medicaid semaglutide Louisiana lawmakers are considering a bill that would expand access to GLP-1 drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Rhode Island considers ending Medicaid

Thyroid concerns: Animal studies showed thyroid tumors with both medications

Retatrutide is being studied in ongoing clinical trials, including programs evaluating obesity, overweight with weight-related conditions, type 2 diabetes, obstructive sleep apnea, osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease

Weeks 12: Introduce short UV on alternate days

1 setmelanotide-treated patient withdrew due to vomiting

According to users, they feel more comfortable with themselves, smile more in photos and receive honest compliments that boost them